Act to End NTDs | West FY22 Annual Work Plan

The FY22 Work Plan for the period October 1, 2021 - September 30, 2022 covers the fourth year of the five-year program. The fourth-year work plan continues to build on the previous achievements of the program and consider lessons learned.  It aims to achieve the following three intermediate results (IRs):

  • IR1: Increased mass drug administration (MDA) coverage among at-risk populations in endemic countries
  • IR2: Strengthened country environment for implementation and management of national NTD programs (NTDPs)
  • IR3: Sustained MDA coverage among at-risk populations in endemic countries
screengrab of FY22 work plan cover
Type
Work Plan
Year of publication
Disease
All Preventive Chemotherapy NTDs, Lymphatic Filariasis, Onchocerciasis, Schistosomiasis, Soil-Transmitted Helminthiasis, Trachoma
Country
All Countries, Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone, Togo
Focus Areas
Mass Drug Administration (MDA), MDA implementation, Community outreach, Drug procurement & supply chain support, Cross-border initiatives, Annual training for MDA, Support for NTD Sustainability, Advocacy and policies, Cross-sector collaboration, NTD governance, Strategic health information, NTD Capacity Building, Monitoring, Evaluation, Research, Learning and Adapting (MERLA), Disease-specific assessments, post-treatment surveillance, and related training, Disease & morbidity mapping & assessment, Learning & quality improvement, Data for decision-making, Operational research, Dossier development
Partners
AIM Initiative, Deloitte, FHI360, HDI, HKI, World Vision